COLTENE (CLTN) H2 2024 earnings summary

Executive summary

• Net sales reached CHF 250.3m, up 3.1% year-over-year, with strong growth in North America and a return to profitable growth.

• EBIT margin improved to 10.7% from 8.1% last year, driven by economies of scale, cost control, and operational excellence.

• Net profit rose to CHF 20.5m from CHF 11.9m, with free cash flow increasing to CHF 20.0m.

• Growth achieved despite economic headwinds and market challenges, with market share gains.

• Leadership team strengthened with new appointments in sales and marketing.

Financial highlights

• Net sales grew to CHF 250.3m (+3.1% in CHF, +6.3% in local currencies) compared to prior year.

• EBIT increased 36.9% to CHF 26.8m; EBIT margin at 10.7%.

• Net profit surged 71.3% to CHF 20.5m; net profit margin at 8.2%.

• Free cash flow reached CHF 20.0m, up from CHF 17.4m.

• Effective tax rate decreased to 22.7% from 25.9%.

Outlook and guidance

• Short-term outlook remains volatile due to geopolitical and economic uncertainties.

• Sales expected to grow 3-5% in local currencies for 2025; EBIT margin targeted at 11%.

• Medium-term (2027) targets: annual sales growth of 3-5%, EBIT margin of 13-15%, payout ratio of about 70%.

• Strategic measures and operational improvements expected to support continued growth.